Anatara Lifesciences Ltd (ANR.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -1.24 Million | -2.25 Million | -2.23 Million | -2.09 Million | -2.72 Million | -2.23 Million |
| Net Income | -1.45 Million | -2.02 Million | -2.53 Million | -1.99 Million | -3.36 Million | -2.86 Million |
| Depreciation & Amortization | 2463.00 | 24.76 Thousand | 24.67 Thousand | 6265.00 | 16.09 Thousand | 22.72 Thousand |
| Deferred income taxes | - | -426.6 Thousand | 109.69 Thousand | -272.4 Thousand | -72.28 Thousand | -1.34 Million |
| Stock-based compensation | 28.59 Thousand | 54.62 Thousand | 71.47 Thousand | 117.64 Thousand | 305.74 Thousand | 196.38 Thousand |
| Change in working capital | 343.2 Thousand | -330.37 Thousand | 199.94 Thousand | -225.81 Thousand | 318.18 Thousand | 1.14 Million |
| Other non-cash items | -170.41 Thousand | 442.87 Thousand | -106.37 Thousand | 272.7 Thousand | 72 Thousand | 607.88 Thousand |
| Investing Cash Flow | 50 Thousand | -1726.00 | -56.56 Thousand | -3979.00 | 4.04 Million | 2.15 Million |
| Investments in PPE | -4.00 | -1726.00 | -6561.00 | -3979.00 | -4076.00 | - |
| Acquisitions | - | - | - | - | 1266.00 | - |
| Investment purchases | - | - | -50 Thousand | - | -1.5 Million | -7.05 Million |
| Sales/Maturities of investments | 50 Thousand | - | - | - | 5.55 Million | 9.2 Million |
| Other Investing Activities | 50 Thousand | - | -50 Thousand | - | -1.00 | 9.2 Million |
| Financing Cash Flow | 1.82 Million | 1.49 Million | -22.43 Thousand | 2.85 Million | - | - |
| Debt repayment | - | -18.19 Thousand | -17.43 Thousand | -514.00 | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -188.68 Thousand | -5000.00 | -37.63 Thousand | - | - |
| Common Stock Issuance | 1.82 Million | 1.5 Million | -5000.00 | 2.85 Million | - | - |
| Other Financing Activities | 1.82 Million | 1.49 Million | 32.43 Thousand | 2.85 Million | - | - |
| Accounts receivables | 332.98 Thousand | -495.55 Thousand | 264.03 Thousand | -142.22 Thousand | 265.65 Thousand | 1.14 Million |
| Accounts payables | -225.19 Thousand | 173.1 Thousand | -33.51 Thousand | - | - | -54.96 Thousand |
| Inventory | - | - | - | - | - | 732.75 Thousand |
| Other working capital | 10.21 Thousand | -7929.00 | -30.57 Thousand | -83.59 Thousand | 52.53 Thousand | -677.79 Thousand |
| Cash at beginning of period | 351.18 Thousand | 1.12 Million | 3.43 Million | 2.68 Million | 1.36 Million | 1.44 Million |
| Cash at end of period | 982.1 Thousand | 351.18 Thousand | 1.12 Million | 3.43 Million | 2.68 Million | 1.36 Million |
| Capital Expenditure | -4.00 | -1726.00 | -6561.00 | -3979.00 | -4076.00 | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 630.92 Thousand | -769.02 Thousand | -2.31 Million | 749.7 Thousand | 1.32 Million | -87.65 Thousand |
| Free Cash Flow | -1.24 Million | -2.25 Million | -2.23 Million | -2.1 Million | -2.72 Million | -2.23 Million |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.45 Million | -772.05 Thousand | -679.18 Thousand | -1.06 Million | -2.02 Million | -955.71 Thousand |
| Depreciation & Amortization | 2463.00 | 675.00 | 1788.00 | 11.87 Thousand | 24.76 Thousand | 12.89 Thousand |
| Deferred income taxes | - | - | - | 456.35 Thousand | -426.6 Thousand | - |
| Stock-based compensation | - | 33.18 Thousand | -4581.00 | 15.46 Thousand | 54.62 Thousand | 39.16 Thousand |
| Change in working capital | 118 Thousand | 343.2 Thousand | - | -503.48 Thousand | -330.37 Thousand | - |
| Other non-cash items | -19.48 Thousand | -563.35 Thousand | 391.93 Thousand | -171.45 Thousand | 442.87 Thousand | -38.49 Thousand |
| Investing Cash Flow | 50 Thousand | 50 Thousand | - | -585.00 | -1726.00 | -1141.00 |
| Investments in PPE | - | - | - | - | -1726.00 | -1726.00 |
| Acquisitions | - | - | - | -585.00 | - | 585.00 |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 50 Thousand | 50 Thousand | - | - | - | - |
| Other Investing Activities | - | 50 Thousand | - | -585.00 | - | 585.00 |
| Financing Cash Flow | 1.82 Million | 855.91 Thousand | 972.4 Thousand | 255.71 Thousand | 1.49 Million | 1.23 Million |
| Debt repayment | - | - | - | - | -18.19 Thousand | -11.53 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -188.68 Thousand | - |
| Common Stock Issuance | 1.82 Million | 855.91 Thousand | 972.4 Thousand | 262.37 Thousand | 1.5 Million | 1.24 Million |
| Other Financing Activities | - | 855.91 Thousand | 972.4 Thousand | 255.71 Thousand | 1.49 Million | 1.24 Million |
| Accounts receivables | 332.98 Thousand | 332.98 Thousand | - | -495.55 Thousand | -495.55 Thousand | - |
| Accounts payables | -225.19 Thousand | - | - | - | 173.1 Thousand | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 10.21 Thousand | 10.21 Thousand | - | -7929.00 | -7929.00 | - |
| Cash at beginning of period | 351.18 Thousand | 1.03 Million | 351.18 Thousand | 1.34 Million | 1.12 Million | 1.12 Million |
| Cash at end of period | 932.01 Thousand | 932.01 Thousand | 1.03 Million | 351.18 Thousand | 351.18 Thousand | 1.34 Million |
| Capital Expenditure | - | - | - | - | -1726.00 | -1726.00 |
| Effect of forex changes on cash | - | - | - | -351.18 Thousand | - | 1.12 Million |
| Net cash flow / Change in cash | 580.83 Thousand | -102.52 Thousand | 683.35 Thousand | -995.66 Thousand | -769.02 Thousand | 226.64 Thousand |
| Free Cash Flow | -1.24 Million | -958.35 Thousand | -289.04 Thousand | -1.25 Million | -2.25 Million | -1 Million |
0159
KITS
ABN
LQZ
DUCON
0468